The European Union's drug regulator said Thursday it was recommending that an antibody medication developed by AstraZeneca be authorized to help some vulnerable people avoid getting sick with the coronavirus.
The European Medicines Agency said in a statement that it was advising that the new drug, sold as Evusheld, be used in people age 12 and over before they were exposed to COVID-19, to prevent future infections.
